| Pre-clinical pharmacokinetic characterization, tissue distribution, and excretion studies of novel edaravone oral prodrug, TEJ-1704 DW Kang, JH Kim, KM Kim, S Cho, HW Jang, JW Chang, SM Dong, ... Pharmaceutics 13 (9), 1406, 2021 | 4 | 2021 |
| Parent-metabolite pharmacokinetic modeling of formononetin and its active metabolites in rats after oral administration of formononetin formulations JH Kim, DW Kang, S Cho, HY Cho Pharmaceutics 15 (1), 45, 2022 | 3 | 2022 |
| Strategies for developing Alzheimer’s disease treatments: application of population pharmacokinetic and pharmacodynamic models DW Kang, S Cho, GW Choi, HY Cho Journal of Pharmaceutical Investigation 52 (5), 519-538, 2022 | 3 | 2022 |
| Population pharmacokinetic modeling and simulation of choline in healthy Korean subjects after oral administration of choline alfoscerate AG Im, GW Choi, DW Kang, S Cho, J Kim, KY Kim, HY Cho Journal of Pharmaceutical Investigation 52 (3), 331-339, 2022 | 2 | 2022 |
| Physiologically-based pharmacokinetic model for evaluating gender-specific exposures of N-nitrosodimethylamine (NDMA) DW Kang, JH Kim, GW Choi, S Cho, HY Cho Archives of Toxicology 98 (3), 821-835, 2024 | 1 | 2024 |
| Integration of modern science into herbal medicine: application of pharmacokinetic-pharmacodynamic modeling in understanding nonclinical study of Cinnamomum cassia extract. JH Kim, YB Hong, DW Kang, S Cho, HJ Seo, HY Cho Journal of Pharmaceutical Investigation, 1-13, 2024 | | 2024 |
| Sex, age, and species differences of perfluorooctanoic acid modeled by flow-versus permeability-limited physiologically-based pharmacokinetic models GW Choi, DW Kang, JH Kim, S Cho, YB Lee, IH Kwon, HY Cho Toxicology 505, 153806, 2024 | | 2024 |
| Multicompartmental pharmacokinetic evaluation of enavogliflozin eye drop formulation: Understanding its distribution to posterior segments S Cho, DW Kang, JH Kim, GW Choi, M Kang, HY Cho Journal of Pharmaceutical Investigation, 1-15, 2024 | | 2024 |
| Study on the Reliability Improvement of Health Functional Foods: The Regulatory Operation and Management of Institution Conducting Human Study in Korea S Cho, YB Hong, DW Kang, HY Cho Food Supplements and Biomaterials for Health 2 (2), 2022 | | 2022 |
